Helen Susan Kim, EVP, Business Development at Kite Pharma, Inc. (KITE), sold 50,300 shares at $63.00 ($3.4M) on 2017-02-28, disclosed to the SEC on 2017-03-02.
Open-market sale of $3.4M KITE by EVP, Business Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $63.00 | 2,400 | $151K | 4.4% |
| 2 | $65.81 | 18,072 | $1.2M | 34.9% |
| 3 | $66.32 | 10,326 | $685K | 20.1% |
| 4 | $67.49 | 2,500 | $169K | 4.9% |
| 5 | $68.74 | 900 | $62K | 1.8% |
| 6 | $69.63 | 2,553 |
| $178K |
| 5.2% |
| 7 | $71.16 | 9,049 | $644K | 18.9% |
| 8 | $71.65 | 1,800 | $129K | 3.8% |
| 9 | $72.60 | 300 | $22K | 0.6% |
| 10 | $68.95 | 200 | $14K | 0.4% |
| 11 | $70.29 | 300 | $21K | 0.6% |
| 12 | $71.23 | 200 | $14K | 0.4% |
| 13 | $72.69 | 200 | $15K | 0.4% |
| 14 | $73.64 | 100 | $7K | 0.2% |
| 15 | $75.52 | 200 | $15K | 0.4% |
| 16 | $76.93 | 200 | $15K | 0.5% |
| 17 | $79.26 | 600 | $48K | 1.4% |
| 18 | $79.92 | 400 | $32K | 0.9% |
| Total | $67.78 avg | 50,300 | $3.4M | 100% |
| Filing → |
| AMTI | SELL | 2021-08-25 | $585K | — | Filing → |
| AMTI | SELL | 2021-07-06 | $17.3M | — | Filing → |
| KITE | SELL | 2017-09-27 | $1.1M | — | Filing → |